Twist Bioscience Corp Stock Filter Stocks by Fundamentals
| TWST Stock | USD 48.17 1.06 2.15% |
Twist Bioscience Corp fundamentals help investors to digest information that contributes to Twist Bioscience's financial success or failures. It also enables traders to predict the movement of Twist Stock. The fundamental analysis module provides a way to measure Twist Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Twist Bioscience stock.
Twist | Shares Owned by Institutions |
Twist Bioscience ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Twist Bioscience's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Twist Bioscience's managers, analysts, and investors.Environmental | Governance | Social |
Twist Bioscience Institutional Holders
Institutional Holdings refers to the ownership stake in Twist Bioscience that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Twist Bioscience's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Twist Bioscience's value.| Shares | Geode Capital Management, Llc | 2024-09-30 | 1.4 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 991.1 K | Thrivent Financial For Lutherans | 2024-09-30 | 973.7 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 962.2 K | Goldman Sachs Group Inc | 2024-09-30 | 921.4 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 880.2 K | Baillie Gifford & Co Limited. | 2024-09-30 | 834.3 K | Tao Capital Management Lp | 2024-09-30 | 828.8 K | Wellington Management Company Llp | 2024-09-30 | 797.7 K | Artisan Partners Limited Partnership | 2024-09-30 | 6 M | Vanguard Group Inc | 2024-09-30 | 5.6 M |
Twist Fundamentals
| Return On Equity | -0.38 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.75) % | ||||
| Operating Margin | (0.54) % | ||||
| Current Valuation | 2.67 B | ||||
| Shares Outstanding | 59.36 M | ||||
| Shares Owned By Insiders | 1.94 % | ||||
| Shares Owned By Institutions | 98.06 % | ||||
| Number Of Shares Shorted | 8.95 M | ||||
| Price To Book | 6.05 X | ||||
| Price To Sales | 9.68 X | ||||
| Revenue | 312.97 M | ||||
| Gross Profit | 84.23 M | ||||
| EBITDA | (176.71 M) | ||||
| Net Income | (208.73 M) | ||||
| Cash And Equivalents | 504.97 M | ||||
| Cash Per Share | 8.93 X | ||||
| Total Debt | 85.03 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 6.58 X | ||||
| Book Value Per Share | 8.39 X | ||||
| Cash Flow From Operations | (64.09 M) | ||||
| Short Ratio | 15.97 X | ||||
| Earnings Per Share | (3.60) X | ||||
| Price To Earnings To Growth | (0.04) X | ||||
| Target Price | 51.81 | ||||
| Number Of Employees | 919 | ||||
| Beta | 1.78 | ||||
| Market Capitalization | 2.86 B | ||||
| Total Asset | 614.32 M | ||||
| Retained Earnings | (1.24 B) | ||||
| Working Capital | 275.77 M | ||||
| Net Asset | 614.32 M |
About Twist Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Twist Bioscience Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Twist Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Twist Bioscience Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.